Fig. 2From: Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic settingRotavirus outcome tree and different healthcare paths considered in model. With permission from Bruijning-Verhagen et al. [11]Back to article page